Trial Condition(s):
Skin Aging, Postmenopause, Hormone Replacement Therapy
Study to evaluate the effect of SH T 641 CA on skin and hair in postmenopausal women
Bayer Identifier:
90834
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
93
Trial Dates
Phase
3
Could I receive a placebo?
No
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
Status
| Locations | Status |
|---|
Trial Design
Double-blind, placebo-controlled, parallel group study on the effects of SH T 641 CA on skin and hair of female healthy postmenopausal volunteers
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
